Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,431
archived clinical trials in
Back Pain

SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Pacific Pain Medicine Consultants
mi
from
Oceanside, CA
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Pacific Pain Medicine Consultants
mi
from
Oceanside, CA
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Pain and Spine Center
mi
from
Dayton, OH
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Pain and Spine Center
mi
from
Dayton, OH
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Pain Care LLC
mi
from
Stockbridge, GA
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Pain Care LLC
mi
from
Stockbridge, GA
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Pasadena Rehabilitation Institute
mi
from
Pasadena, CA
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Pasadena Rehabilitation Institute
mi
from
Pasadena, CA
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Performance Spine and Sports Physicians
mi
from
Pottstown, PA
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Performance Spine and Sports Physicians
mi
from
Pottstown, PA
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
The Center for Pain Relief
mi
from
Charleston, WV
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
The Center for Pain Relief
mi
from
Charleston, WV
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
The Mocek Spine Clinic
mi
from
Little Rock, AR
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
The Mocek Spine Clinic
mi
from
Little Rock, AR
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
The Pain Center of Arizona
mi
from
Phoenix, AZ
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
The Pain Center of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Valley Pain Consultants - N. Scottsdale
mi
from
Scottsdale, AZ
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Valley Pain Consultants - N. Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated:  4/11/2016
Vertex Spine and Pain
mi
from
Franklin, TN
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain
Status: Enrolling
Updated: 4/11/2016
Vertex Spine and Pain
mi
from
Franklin, TN
Click here to add this to my saved trials
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
Status: Enrolling
Updated:  5/4/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
Status: Enrolling
Updated: 5/4/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Agave Clinical Research
mi
from
Mesa, AZ
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Agave Clinical Research
mi
from
Mesa, AZ
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Arizona Research Center
mi
from
Phoenix, AZ
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Arizona Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Global Research
mi
from
Anaheim, CA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Global Research
mi
from
Anaheim, CA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Neuro-Pain Medical Center
mi
from
Fresno, CA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Neuro-Pain Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Providence Clinical Research
mi
from
North Hollywood, CA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Providence Clinical Research
mi
from
North Hollywood, CA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Elite Clinical Trials, Incorporate
mi
from
Wildomar, CA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Elite Clinical Trials, Incorporate
mi
from
Wildomar, CA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Stamford Therapeutics Consortium
mi
from
Stamford, CT
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Avail Clinical Research
mi
from
DeLand, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
S&W Clinical Research
mi
from
Fort Lauderdale, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
S&W Clinical Research
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Florida Research Network
mi
from
Gainesville, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Florida Research Network
mi
from
Gainesville, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Broward Research Group
mi
from
Hollywood, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Broward Research Group
mi
from
Hollywood, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Compass Research LLC
mi
from
Orlando, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Accord Clinical Research
mi
from
Port Orange, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Arthritis and Rheumatic Care Center
mi
from
South Miami, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Arthritis and Rheumatic Care Center
mi
from
South Miami, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Miami Research Associates
mi
from
South Miami, FL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Better Health Clinical Research, Inc.
mi
from
Atlanta, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Better Health Clinical Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
River Birch Research Alliance
mi
from
Blue Ridge, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
River Birch Research Alliance
mi
from
Blue Ridge, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Columbus Regional Research Institute
mi
from
Columbus, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Columbus Regional Research Institute
mi
from
Columbus, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Family Medicine center
mi
from
Columbus, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Family Medicine center
mi
from
Columbus, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Drug Studies America
mi
from
Marietta, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Drug Studies America
mi
from
Marietta, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Better Health Clinical Research
mi
from
Newnan, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Better Health Clinical Research
mi
from
Newnan, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Better Health Clinical Research, Inc./Georgia Pain & Spine Care, Inc.
mi
from
Newnan, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Better Health Clinical Research, Inc./Georgia Pain & Spine Care, Inc.
mi
from
Newnan, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Southeast Regional Research Group
mi
from
Savannah, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Southeast Regional Research Group
mi
from
Savannah, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
North Georgia Clinical Research
mi
from
Woodstock, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
North Georgia Clinical Research
mi
from
Woodstock, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
North Georgia Internal Medicine
mi
from
Woodstock, GA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
North Georgia Internal Medicine
mi
from
Woodstock, GA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Chicago Anesthesia Associates
mi
from
Chicago, IL
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Chicago Anesthesia Associates
mi
from
Chicago, IL
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Centex Studies, Inc.
mi
from
Lake Charles, LA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Centex Studies, Inc.
mi
from
Lake Charles, LA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Boston Clinical Trials, INC.
mi
from
Boston, MA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
ActivMed Practices & Research
mi
from
Methuen, MA
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
CRC of Jackson
mi
from
Jackson, MS
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
CRC of Jackson
mi
from
Jackson, MS
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Physician's Surgery Center
mi
from
Jackson, MS
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Physician's Surgery Center
mi
from
Jackson, MS
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Drug Trials America
mi
from
Hartsdale, NY
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Drug Trials America
mi
from
Hartsdale, NY
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
AAIR Research Center
mi
from
Rochester, NY
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
AAIR Research Center
mi
from
Rochester, NY
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Wake Internal Medicine Consultants, Inc.
mi
from
Raleigh, NC
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Wake Internal Medicine Consultants, Inc.
mi
from
Raleigh, NC
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Wake Research Associates, LLC
mi
from
Raleigh, NC
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
The Center for Clinical Research
mi
from
Winston-Salem, NC
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated:  5/31/2016
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
Status: Enrolling
Updated: 5/31/2016
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials